Suppr超能文献

根治性膀胱切除术治疗的膀胱癌患者高龄的预后意义。

The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy.

作者信息

Resorlu Berkan, Beduk Yasar, Baltaci Sumer, Ergun Gul, Talas Halit

机构信息

Department of Urology, School of Medicine, University of Ankara, Ankara, Turkey.

出版信息

BJU Int. 2009 Feb;103(4):480-3. doi: 10.1111/j.1464-410X.2008.08033.x. Epub 2008 Oct 16.

Abstract

OBJECTIVE

To evaluate the association of patient age with pathological and long-term oncological outcomes after radical cystectomy (RC) for bladder carcinoma, as this disease, like many others, increases in incidence with age.

PATIENTS AND METHODS

We retrospectively reviewed 241 consecutive patients with invasive bladder cancer who had RC between 1990 and 2007. The age at RC was analysed both as a continuous and categorical (< or =50 years, 38 patients; 51-69, 172; or > or =70, 31) variable. Survival was also analysed.

RESULTS

Increasing age, analysed as a continuous and categorical variable, was associated with advanced pathological stage (P = 0.009 and 0.006, respectively). The 5-year cancer-specific survival rates for patients according to the age groups were 78.5%, 44.9% and 28.1%, respectively, and Kaplan-Meier analysis showed an increased risk of bladder cancer-specific death with advancing age (P < 0.001). Being older at RC was an important prognostic factor for disease-specific survival in a multivariate Cox regression model. Patients aged > or =70 years had a significantly higher risk of disease than patients aged < or =50 years (P = 0.002).

CONCLUSIONS

Higher age at RC is significantly associated with the risk of pathologically advanced disease and poorer cancer-specific survival. More prospective work is needed to examine the impact of age on tumour biology and cancer-specific survival.

摘要

目的

评估膀胱癌根治性膀胱切除术(RC)后患者年龄与病理及长期肿瘤学结局之间的关联,因为这种疾病与许多其他疾病一样,发病率会随年龄增长而升高。

患者与方法

我们回顾性分析了1990年至2007年间连续接受RC治疗的241例浸润性膀胱癌患者。将RC时的年龄作为连续变量和分类变量(≤50岁,38例患者;51 - 69岁,172例;≥70岁,31例)进行分析。同时对生存率也进行了分析。

结果

将年龄作为连续变量和分类变量进行分析时,年龄增加均与病理分期进展相关(分别为P = 0.009和0.006)。各年龄组患者的5年癌症特异性生存率分别为78.5%、44.9%和28.1%,Kaplan - Meier分析显示,随着年龄增长,膀胱癌特异性死亡风险增加(P < 0.001)。在多变量Cox回归模型中,RC时年龄较大是疾病特异性生存的重要预后因素。≥70岁的患者比≤50岁的患者疾病风险显著更高(P = 0.002)。

结论

RC时年龄较大与病理分期进展风险及较差的癌症特异性生存显著相关。需要更多前瞻性研究来探讨年龄对肿瘤生物学和癌症特异性生存的影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验